Skip to main content
Clinical Trials/NCT01849614
NCT01849614
Completed
Not Applicable

Prospective Pilot Study of Assessment of Breath Hold as a Means to Mitigate the Risk of Radiation-associated Reductions in Regional Cardiac Perfusion in Patients With Left-sided Breast Cancer

UNC Lineberger Comprehensive Cancer Center1 site in 1 country25 target enrollmentMarch 2013
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
25
Locations
1
Primary Endpoint
Changes in cardiac perfusion
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this research study is to demonstrate that Deep Inspiration Breath Hold (DIBH), the technique used at the University of North Carolina (UNC) for left-side breast cancer radiation therapy, can reduce side effects to the heart.

Detailed Description

The primary objective of this study is to estimate the rate of radiation-associated regional myocardial perfusion defects in patients 6 months after breast/chestwall radiation with DIBH for left-sided breast cancer. Cardiac perfusion will be assessed using SPECT cardiac perfusion scans pre- and 6 months post-radiation.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
March 2016
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • signed an Institutional Review Board (IRB)-approved informed consent document for protocol
  • age \>= 18 years
  • histologically confirmed left-sided breast cancer scheduled to undergo curative intent radiation treatment post lumpectomy or mastectomy
  • stage 0-III left-sided breast cancer (including DCIS)
  • SPECT score of 0 at baseline
  • radiation oncologist agrees target volume coverage will not be compromised via use of the DIBH technique along with conformal field shaping

Exclusion Criteria

  • active cardiac disease, defined as a history of angina, arrhythmias, myocardial infarction, congestive heart failure, or any other cardiac condition, which in the opinion of the treating physician would make this protocol unreasonably hazardous for the patient
  • symptomatic pulmonary disease currently requiring regular medication including but not restricted to bronchodilators
  • concurrent chemotherapy
  • prior receipt of mediastinal radiation therapy
  • pregnant or lactating women
  • inability to understand and follow breathing instructions for the DIBH procedure

Outcomes

Primary Outcomes

Changes in cardiac perfusion

Time Frame: 6-months post radiation

Cardiac perfusion will be assessed using SPECT cardiac perfusion scans pre- and 6 months post-radiation. Any post-radiation summed-rest score (SRS) \> 0 will be counted as a perfusion defect in the calculation of the perfusion defect rate.

Secondary Outcomes

  • Wall-motion abnormalities(6-months post-treatment)

Study Sites (1)

Loading locations...

Similar Trials